Prior to COVID‑19 life expectancy at age 65 for the period 2015‑20 was 83.1 years for men and 86.3 years for women, on average (OECD, 2021). These are virtually the same levels that apply in 2022, as men were at 83.0 years and women at 86.2 years for the OECD average (Figure 6.2). The highest levels are found in Japan for women, at 89.9 years, with France, Italy, Korea and Spain also above 88 years. For men Australia, Canada, France, Italy, Japan, New Zealand and Switzerland are all at 85.0 years or above. The lowest levels for women are in Colombia (82.8 years), Hungary (82.5 years) and the Slovak Republic (82.5 years) with Hungary (78.5 years), Lithuania (78.1 years) and the Slovak Republic (78.6 years) being lowest for men.
There is considerable variation between OECD countries in life expectancy at older ages. Women in Japan are predicted to live another 29.1 years on reaching age 65 in 2065, followed by Korea (28.1 years). In contrast, remaining life expectancy at 65 in 2065 for women in both Latvia and Mexico is equal to 22.5 years (Figure 6.3). For men there is less variation between countries than there is for women. Switzerland will have the longest life expectancy at age 65 in 2065 (24.5 years), followed by Australia and New Zealand (24.4 years). By contrast, Latvia (19.3 years) and Mexico (20.0 years) are ranked at the bottom.
The gender gap in life expectancy at age 65 is predicted to be between almost two and four years in favour of women in nearly all OECD countries in 2065. Larger gender gaps of 5 years are observed in both Japan and Korea. The smallest forecasted gender gap of 1.7 years is in Iceland, the Netherlands, the United Kingdom and the United States.
The above numbers refer to period life expectancy, which measures life expectancy (current or projected) based on mortality rates for people of different ages at a given time (2022 or 2065 here) that hence belong to different birth cohorts. By contrast, cohort life expectancy is based on the projected mortality rates that would apply to the same birth cohort at different ages. It thus takes account of continuing improvements (after 2022 or 2065) that would benefit a given birth cohort. On average, these cohort estimates add 1.3 years for women aged 65 in 2065 and 1.0 years for men (Figure 6.3).
Between 2019 and 2020 life expectancy at age 65 decreased for men from 20.7 years to 19.9 years and for women from 24.6 years to 24.0 years, though both recovered their 2019 levels again by 2022.
Improvements in remaining life expectancy at age 65 has recently slowed from a period of fast longevity gains. The trend in the pace of old-age life-expectancy peaked in the mid-2000s (Figure 6.4) for both men and women. This slowdown leads to a structural break in the series in 2012‑13 in the OECD on average. Between the mid‑1990s and 2012 for women and 2013 for men the increasing trend in life expectancy at age 65 was fast at around 1.5 years for men per decade and 1.4 years for women, an acceleration from 0.8 and 1.0 years per decade before, respectively. Since 2012‑13, the estimated structural trend equals 1.0 and 0.8 years, respectively, with the break in the series being magnified by COVID‑19. However, these estimates should be treated cautiously as they are based on a statistical filtering method which can lead to significant revisions down the road even though this problem has been reduced by using projected life expectancy to compute (current) estimated values (Box 1.1 in (OECD, 2021)).